Juvenile Idiopathic Arthritis
Conditions
Brief summary
A comparison of outcome in children with JIA who are in remission on MTX, when MTX is then stopped for either 6 or 12 months
Interventions
DRUGmethotrexate
Sponsors
Institute of Child Health
Study design
Observational model
DEFINED_POPULATION
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
No minimum to 16 Years
Healthy volunteers
No
Inclusion criteria
* Any child with JIA who has gone into remission using methotrexate
Countries
United Kingdom
Contacts
Primary ContactLucy Wedderburn, Dr
Outcome results
None listed